Department of Hepatobiliary Surgery, Chinese PLA, General Hospital, No 28 Fuxing Road, Beijing 100853, People's Republic of China.
World J Surg. 2011 Mar;35(3):648-55. doi: 10.1007/s00268-010-0919-0.
The present study was designed to explore the safety and feasibility of laparoscopic re-resection of recurrent liver tumors.
Among 120 hepatocellular carcinoma patients who received laparoscopic hepatectomy, six were carefully selected to receive laparoscopic re-resection. Surgical indications were evaluated by specific selection criteria for tumor location, size, metastases, vessel invasion, and liver function. Four patients received laparoscopic partial hepatectomy, and two received laparoscopic anatomical left lateral lobe resection. Results were analyzed retrospectively.
The six surgeries (four laparoscopic partial hepatectomies, two laparoscopic anatomical left lateral lobe resections) were successfully performed with no intraoperative complications. Mean operative time was 140.83 ± 35.69 min, mean blood loss was 283.33 ± 256.25 ml, and mean hospital stay was 5.67 ± 1.63 days.
Our experience with carefully selected cases meeting specific criteria suggests that laparoscopic hepatic re-resection is a safe, feasible procedure that may offer multiple benefits for treating recurrent hepatocellular carcinoma.
本研究旨在探讨腹腔镜再次肝切除治疗复发性肝肿瘤的安全性和可行性。
在 120 例接受腹腔镜肝切除术的肝细胞癌患者中，仔细选择了 6 例接受腹腔镜再次肝切除。通过肿瘤位置、大小、转移、血管侵犯和肝功能的具体选择标准评估手术适应证。4 例患者接受腹腔镜部分肝切除术，2 例患者接受腹腔镜解剖性左外叶切除术。对结果进行回顾性分析。
6 例手术（4 例腹腔镜部分肝切除术，2 例腹腔镜解剖性左外叶切除术）均顺利完成，无术中并发症。平均手术时间为 140.83±35.69min，平均出血量为 283.33±256.25ml，平均住院时间为 5.67±1.63 天。
我们对符合特定标准的精选病例的经验表明，腹腔镜肝再次切除术是一种安全、可行的手术方法，可能为治疗复发性肝细胞癌带来多种益处。
